About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
2020 ASCO Virtual Direct™ Highlights
Boston
Breast
GYN
Lung
GI
GU
Skin
Hematologic Oncology
Head&Neck
Supportive/Palliative Care
St. Louis
Breast
GYN
Lung
GI
GU
Skin
Hematologic Oncology
Head&Neck
Supportive/Palliative Care
Basic Science
Jacksonville
Breast
Hematologic Oncology
Lung
GI
GU
GYN
Skin
Head&Neck
Basic Science
Philadelphia
GI
GU
Lung
Skin
Hematologic Oncology
Breast
Supportive/Palliative Care
Head&Neck
GYN
Denver
Breast
Hematologic Oncology
Lung
GU
Skin
GYN
Head&Neck
Basic Science
San Francisco
Breast
Lung
GU
Hematologic Oncology
Skin
GI
GYN
Head&Neck
Business
Las Vegas
GI
GU
Hematologic Oncology
Skin
Lung
Head&Neck
GYN
Business
San Juan
Breast
GI
Hematologic Oncology
Skin
GYN
Basic Science
Head and Neck
Supportive and Palliative Care
Business
Events
Basic Science
14:05
2020 ASCO Virtual Direct™ Highlights
ASCO 2020 Update on ctDNA Testing: What Are the Clinical Uses of ctDNA and Potential Drawbacks? What Are the MONALEESA Trial Outcomes?
FEATURING
Gregory Botta
14 views
February 11, 2021
05:43
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on cfDNA Analysis Among Carcinoma of Unknown Primary Patients: What Are Genomic Targets of Interest Based on OncoKB Annotation?
FEATURING
Gregory Botta
14 views
February 11, 2021
08:38
2020 ASCO Virtual Direct™ Highlights
ASCO 2020 Update on ctDNA & MRD Testing in mCRPC: What Is Prognostic Value of Plasma cfDNA Useful in GMB Patients? What Are the Limitations?
FEATURING
Gregory Botta
8 views
February 11, 2021
10:05
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on ctDNA and MRD Testing: What Is the Post-Therapy Relapse Risk in ctDNA-Positive Patients? Can ctDNA Analysis Help Guide Treatment Decisions?
FEATURING
Gregory Botta
6 views
February 11, 2021